BRAF and melanoma: The expert panel of oncologists and pathologists from Argentina, Brazil, Colombia, Costa Rica, and Mexico shared their experiences and polled colleagues to provide insight into current clinical practice for patients with BRAF-mutated melanoma and CRC.